Vitamin D deficiency and mortality among critically ill surgical patients in an urban Korean hospital
Abstract
Abstract. Critically ill patients in intensive care units (ICUs) are exposed to various risk factors for vitamin D deficiency. Vitamin D deficiency in extended-stay patients may result in decreased muscle mass and increased fat tissue, which may impair rehabilitation and recovery. Our study aimed to evaluate the degree of serum vitamin D deficiency in critically ill surgical patients and its association with clinical outcomes. Clinical data from 186 adult male (n = 121; 65.1%) and female (n = 65; 34.9%) patients hospitalized in surgical ICUs at Ajou University Hospital from April 2015 to September 2016 were retrospectively analyzed. All adult surgical patients between the age of 18 and 88 years were enrolled. The mean serum 25-hydroxyvitamin D (25[OH]D) level of all patients was 17.8 ng/mL. A total of 120 patients (64.5%) with serum 25(OH)D levels < 20 ng/mL were classified as the deficiency group. A prolonged hospital stay was observed among the deficiency group but was not statistically significant (p = 0.824). Serum 25(OH)D levels were significantly correlated with age but inversely correlated with Sequential Organ Failure Assessment (SOFA) score, selenium, triglycerides, and C-reactive protein levels. There was no significant difference in mortality rates between the group with a vitamin D injection and the group without a vitamin D injection (14.6% vs. 16.9%, p = 0.074). Vitamin D deficiency was common in surgical ICU patients; however, vitamin D levels were higher in older patients. In conclusion, vitamin D deficiency was inversely associated with the SOFA severity score (correlation coefficient –0.165, p = 0.024) but was not associated with the length of hospital or ICU stay and mortality.
References
1 . Vitamin D actions to regulate calcium and skeletal homeostasis. Clin Biochem. 2012;45:880–6.
2 . Vitamin D deficiency. N Engl J Med. 2007;357:266–81.
3 . Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev. 2001;22:477–501.
4 . Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634–9.
5 Dietary protein intake and risk of osteoporotic hip fracture in elderly residents of Utah. J Bone Miner Res. 2004;19:537–45.
6 . The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007;92:2017–29.
7 Serum 25-hydroxyvitamin D, calcium intake, and risk of type 2 diabetes after 5 years: results from a national, population-based prospective study (the Australian Diabetes, Obesity and Lifestyle study). Diabetes Care. 2011;34:1133–8.
8 . Vitamin D and cancer incidence in the Harvard cohorts. Ann Epidemiol. 2009;19:84–8.
9 . Prostate Cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control. 2000;11:847–52.
10 . Vitamin D: epidemiology of cardiovascular risks and events. Best Pract Res Clin Endocrinol Metab. 2011;25:633–46.
11 Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008;117:503–11.
12 . Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr. 2004;80:S1678–88.
13 . Vitamin D in systemic lupus erythematosus. Curr Opin Rheumatol. 2008;20:532–7.
14 Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study. The Lancet. 2000;355:618–21.
15 . Hypercalcemia due to hypervitaminosis D: report of seven patients. J Trop Pediatr. 2009;55:396–8.
16 . Vitamin D in critically ill patients. Anaesthesiology Intensive Therapy. 2016;48:201–7.
17 Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2011;96:1911–30.
18 . Vitamin D insufficiency in Korea – a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab. 2011;96(3):643–51.
19 . Serum 25-hydroxyvitamin D concentrations and prevalence estimates of hypovitaminosis D in the U.S. population based on assay-adjusted data. J Nutr. 2012;142:498–507.
20 . Incidence and risk factors of vitamin D deficiency in critically ill patients: results from a prospective observational study. Intensive Care Med. 2010;36:1609–11.
21 . Vitamin D deficiency in critically ill patients. N Engl J Med. 2009;360:1912–14.
22 . Relationship between vitamin D status and ICU outcomes in veterans. J Am Med Dir Assoc. 2011;12:208–11.
23 . The relationship between Vitamin D, clinical outcomes and mortality rate in ICU patients: a prospective observational study. J Res Med Sci. 2016;21:75.
24 . Prevalence and significance of low 25-hydroxyvitamin D concentrations in healthy subjects in Delhi. Am J Clin Nutr. 2000;72:472–5.
25 . Prevalence and related factors of vitamin D deficiency in critically ill patients. Korean J Crit Care Med. 2016;31:300–7.
26 . Vitamin D levels and prevalence of vitamin D deficiency associated with sex, age, region, and season in Koreans. Lab Med Online. 2015;5:84.
27 Vitamin D status and its association with season, hospital and sepsis mortality in critical illness. Crit Care. 2014;18(R47):1–12.
28 . Vitamin D deficiency is associated with mortality in the medical intensive care unit. Crit Care. 2011;15:R292.
29 . Low serum 25-hydroxyvitamin D at critical care initiation is associated with increased mortality. Crit Care Med. 2012;40:63–72.
30 . Vitamin D deficiency is associated with poor outcomes and increased mortality in severely ill patients. QJM. 2012;105(7):633–9.
31 . Low serum 25(OH)D at critical care initiation is associated with sepsis and morbidity in Dutch critically ill patients. Critical Care. vol. 19. Brussels, Belgium: 35th International Symposium on Intensive Care and Emergency Medicine; 2015.
32 . Burden and outcome of vitamin D deficiency among critically ill patients: a prospective study. Nutr Clin Pract. 2017;32(3):378–84.
33 . Vitamin D and inflammatory diseases. J Inflamm Res. 2014;7:69–87.
34 Vitamin D status and outcomes in heart failure patients. Eur J Heart Fail. 2011;13(6):619–25.
35 . The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Biol Pharm Bull. 2005;28:1418–23.
36 . Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review. Endocr Pract. 2014;20(4):341–351.
37 . Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204–10.
38 . Vitamin D supplementation in the critically ill: a systematic review and meta-analysis. Clin Nutr. 2018;37(4):1238–46.
39 . Bone turnover in prolonged critical illness: effect of vitamin D. J Clin Endocrinol Metab. 2003;88(10):4623–32.
40 Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials. J Crit Care. 2017;38:109–14.
41 . Vitamin D: daily vs. monthly use in children and elderly – what is going on? Nutrients. 2017;9 (7):652.